Offerings / Regulation CF / Pirouette Pharma Inc.
Pirouette Pharma Inc.
Regulation Crowdfunding offering on Wefunder · Form C filed February 9, 2026 · Portsmouth, New Hampshire
Repeat issuerSAFEPre-revenueCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on June 8, 2017, based in Portsmouth, NH, with 13 employees and $0 of revenue in its most recent fiscal year.
Offering terms
- Security
- Simple Agreement for Future Equity (SAFE)
- Maximum
- $2,376,381.00
- Price
- $1.00 per unit
- Pricing method
- Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.
- Deadline
- April 30, 2026
- Oversubscriptions
- Accepted
- Intermediary
- Wefunder Portal LLC
Funding portal, SEC file 007-00033 - Intermediary fee
- <p>5.0% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.</p>
- Intermediary equity
- No
- Co-issuer
- Pirouette Pharma IV, a series of Wefunder SPV, LLC
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of goods sold | $0 | $0 |
| Net income (loss) | -$4,050,003 | -$3,597,016 |
| Total assets | $3,878,452 | $4,504,151 |
| Cash and equivalents | $1,610,924 | $2,094,498 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $497,330 | $190,461 |
| Long-term debt | $7,388,869 | $4,271,434 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 13 employees. Offered in 56 states.